Nextera XT

Nextera XT

Allows the preparation of sequencing-ready libraries for small genomes, amplicons, and plasmids in less than 90 minutes with only 15 minutes of hands-on time. Amplicon inputs are required be at least 300 bp in length.

Catalog ID(s)
FC-131-1024 Nextera XT DNA Library Prep Kit (24 samples)
FC-131-1096 Nextera XT DNA Library Prep Kit (96 samples)
Even if you do not plan to index, use one of the following Nextera XT Index kits (note that these index kits are not chemically equivalent to the Nextera DNA index kits [not interchangeable])
FC-131-1001 Nextera XT Index Kit (24 indices, 96 samples)
FC-131-1002 Nextera XT Index Kit (96 indices, 384 samples)
FC-131-2001 Nextera XT Index Kit v2 Set A (96 indices, 384 samples)
FC-131-2002 Nextera XT Index Kit v2 Set B (96 indices, 384 samples)
FC-131-2003 Nextera XT Index Kit v2 Set C (96 indices, 384 samples)
FC-131-2004 Nextera XT Index Kit v2 Set D (96 indices, 384 samples)
Order Now Support Training

Please rotate your device for details

* Library prep is compatible with all Illumina instruments. Recommended instruments chosen based on typical output and analysis need for selected application.
† Coverage recommendation depends on application and can range from 100x – 1000x mean coverage.
Project Recommendations
Species Compatibility All species
Recommended Illumina Instrument* MiSeq NextSeq 500
Recommended Samples per run Up to 384 Up to 384
Run Mode - Mid Output High Output
Max Recommended Read Length Up to 2x300 bp Up to 2x150 bp Up to 2x150 bp
Recommended Secondary Analysis
  • MiSeq Reporter PCR Amplicon Workflow
  • FASTQ files with 3rd party analysis
Recommended Down Stream Analysis VariantStudio VariantStudio
Order Now Support Training
For Research Use Only

Not for use in diagnostic procedures.

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.